Department of Clinical Pharmacy and Toxicology, Leiden University Medical Center, Leiden, The Netherlands.
J Immunother. 2011 Apr;34(3):307-19. doi: 10.1097/CJI.0b013e318213cb90.
Opportunistic viral infections can cause serious morbidity and mortality in immunocompromised patients after allogeneic stem cell transplantation. Clinical studies have shown that adoptive transfer of donor-derived T cells specific for cytomegalovirus (CMV), Epstein-Barr virus (EBV), or human adenovirus (HAdV) can be a safe and effective treatment of infections with these major viral pathogens. The aim of this study was to develop a method for the simultaneous isolation of coordinated CD8(+) and CD4(+) memory T-cell responses against a broad repertoire of viral epitopes. To ensure that the method was applicable to a wide variety of virus-specific T cells that may differ in phenotypic and functional properties, we focused on T cells specific for the persistent viruses, CMV and EBV, and T cells specific for HAdV and influenza (FLU), which are not repetitively activated in vivo after initial viral clearance. Following in vitro activation, nearly all T cells specific for these viruses produced interferon γ (IFN-γ) and tumor necrosis factor α, and expressed CD137, whereas the populations varied in the production of interleukin-2, degranulation, and expression of phenotypic markers. Different kinetics of IFN-γ production were observed in CMV/EBV-specific T cells and HAdV/FLU-specific T cells. However, after the stimulation of peripheral blood from seropositive donors with viral protein-spanning peptide pools, the activated virus-specific CD8(+) and CD4(+) T cells could be simultaneously isolated by either IFN-γ-based or CD137-based enrichment. This study provides an efficient and widely applicable strategy for the isolation of virus-specific T cells, which may be used for the reconstitution of virus-specific immunity in allogeneic stem cell transplantation recipients.
机会性病毒感染可导致异基因造血干细胞移植后免疫功能低下的患者严重发病和死亡。临床研究表明,过继转移供体来源的、针对巨细胞病毒(CMV)、EB 病毒(EBV)或人类腺病毒(HAdV)的 T 细胞可安全有效地治疗这些主要病毒病原体感染。本研究旨在开发一种同时分离针对广泛病毒表位的协调 CD8(+)和 CD4(+)记忆 T 细胞反应的方法。为确保该方法适用于可能在表型和功能特性上存在差异的各种病毒特异性 T 细胞,我们专注于针对持续性病毒 CMV 和 EBV 的 T 细胞,以及针对 HAdV 和流感(FLU)的 T 细胞,这些病毒在初始病毒清除后不会在体内反复激活。体外激活后,针对这些病毒的几乎所有 T 细胞均产生干扰素 γ(IFN-γ)和肿瘤坏死因子 α,并表达 CD137,而细胞群在白细胞介素-2 的产生、脱颗粒和表型标志物的表达方面存在差异。在 CMV/EBV 特异性 T 细胞和 HAdV/FLU 特异性 T 细胞中观察到 IFN-γ 产生的不同动力学。然而,在用病毒蛋白跨越肽库刺激血清阳性供体的外周血后,通过基于 IFN-γ 或基于 CD137 的富集可同时分离活化的病毒特异性 CD8(+)和 CD4(+)T 细胞。本研究提供了一种高效且广泛适用于分离病毒特异性 T 细胞的策略,该策略可用于异基因造血干细胞移植受者中病毒特异性免疫的重建。